Speaker illustration

Doctor Miguel Frias

University hospitals of Geneva, Geneva (Switzerland)

HIV-infected patients display increased proatherogenic anti-apolipoprotein A1 autoantibodies, inflammatory and metabolomic markers

Event: ESC Congress 2021 - The Digital Experience

Topic: HIV and Cardiovascular Disease

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

Evaluation of antiretroviral therapy on metabolomics and atherogenic markers in HIV patients

Event: ESC Congress 2020

Topic: HIV and Cardiovascular Disease

Session: Inflammatory and Infectious Disorders and Heart Disease

Thumbnail

The presence of anti-apolipoprotein A1 autoantibodies is associated with a pro-atherogenic profile in HIV-infected patients.

Event: ESC Congress 2019

Topic: HIV and Cardiovascular Disease

Session: Immunodeficiency virus (HIV)

Thumbnail